Advertisement
Screener

MiMedx Group, Inc. (MDXG) Deferred State and Local Income Tax Expense (Benefit)

MiMedx Group, Inc. Deferred State and Local Income Tax Expense (Benefit)

MiMedx Group, Inc. (MDXG) reported Deferred State and Local Income Tax Expense (Benefit) of $545.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-25

  • MiMedx Group, Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was $545.00K, a 35.58% decline from fiscal 2024.
  • MiMedx Group, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was $846.00K.
  • MiMedx Group, Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was -$9.14M.
  • MiMedx Group, Inc. deferred state and local income tax expense (benefit) for fiscal 2022 was $0.00.
Period endDeferred State and Local Income Tax Expense (Benefit) 12 monthDeferred State and Local Income Tax Expense (Benefit) 12 month as first filed
2025-12-31$545.00K
10-K · filed 2026-02-25
2024-12-31$846.00K
10-K · filed 2026-02-25
2023-12-31-$9.14M
10-K · filed 2026-02-25
2022-12-31$0.00
10-K · filed 2025-02-26
2021-12-31$0.00
10-K · filed 2024-02-28
2020-12-31$0.00
10-K · filed 2023-02-28
2019-12-31$0.00
10-K · filed 2022-02-28
2018-12-31$6.09M
10-K · filed 2021-03-08
2017-12-31-$7.23M
10-K · filed 2020-07-06
2016-12-31-$398.00K
10-K · filed 2020-03-17
-$16.00K
10-K · filed 2017-03-01
2015-12-31-$1.77M
10-K · filed 2017-03-01
2014-12-31$0.00
10-K · filed 2017-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B